Delivery Order SPE2DB20D9354-SPE2DB24FX7W1
Award Date
7/25/24
Potential Completion Date
7/26/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a ceiling value of $12,934.05 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, with a ceiling value of $12,934.05 and a completion date of February 5, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,934.05 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $12,934.05, is for the delivery of 4,565,178,916 units of the pharmaceutical product XTANDI 40 MG CAPSULE 120S. The contract has a ceiling value of $12,934.05 and an ultimate completion date of July 18, 2024. DMS Pharmaceutical Group Inc. provides a wide range of...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The contract is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The award has a ceiling value of $12,934.05 and an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,311.35 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $43,113.50 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a completion date of June 12, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, with a ceiling value of $8,622.72 and a performance period through June 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract, valued at $12,934.05, is for the delivery of XTANDI 40 MG CAPSULE 120S. The contract has a completion date of February 22, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XTANDI 40 MG CAPSULE 120S. The contract is a firm fixed-price delivery order with a ceiling value of $12,934.05 and an ultimate completion date of April 21, 2025. DMS Pharmaceutical Group Inc. is the prime contractor and there are no major subcontractors mentioned. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...